|
1
|
Kagan HM and Trackman PC: Properties and
function of lysyl oxidase. Am J Respir Cell Mol Biol. 5:206–210.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith-Mungo LI and Kagan HM: Lysyl
oxidase: Properties, regulation and multiple functions in biology.
Matrix Biol. 16:387–398. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hämäläinen ER, Jones TA, Sheer D, Taskinen
K, Pihlajaniemi T and Kivirikko KI: Molecular cloning of human
lysyl oxidase and assignment of the gene to chromosome 5q23.3–31.2.
Genomics. 11:508–516. 1991.PubMed/NCBI
|
|
4
|
Kim Y, Boyd CD and Csiszar K: A new gene
with sequence and structural similarity to the gene encoding human
lysyl oxidase. J Biol Chem. 270:7176–7182. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jourdan-Le Saux C, Tronecker H, Bogic L,
Bryant-Greenwood GD, Boyd CD and Csiszar K: The LOXL2 gene encodes
a new lysyl oxidase-like protein and is expressed at high levels in
reproductive tissues. J Biol Chem. 274:12939–12944. 1999.PubMed/NCBI
|
|
6
|
Mäki JM and Kivirikko KI: Cloning and
characterization of a fourth human lysyl oxidase isoenzyme. Biochem
J. 355:381–387. 2001.PubMed/NCBI
|
|
7
|
Asuncion L, Fogelgren B, Fong KS, Fong SF,
Kim Y and Csiszar K: A novel human lysyl oxidase-like gene (LOXL4)
on chromosome 10q24 has an altered scavenger receptor cysteine rich
domain. Matrix Biol. 20:487–491. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kenyon K, Contente S, Trackman PC, Tang J,
Kagan HM and Friedman RM: Lysyl oxidase and rrg messenger RNA.
Science. 253:8021991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Giampuzzi M, Botti G, Cilli M, Gusmano R,
Borel A, Sommer P and Di Donato A: Down-regulation of lysyl
oxidase-induced tumorigenic transformation in NRK-49F cells
characterized by constitutive activation of ras proto-oncogene. J
Biol Chem. 276:29226–29232. 2001. View Article : Google Scholar
|
|
10
|
Erler JT, Bennewith KL, Nicolau M,
Dornhöfer N, Kong C, Le QT, Chi JT, Jeffrey SS and Giaccia AJ:
Lysyl oxidase is essential for hypoxia-induced metastasis. Nature.
440:1222–1226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schietke R, Warnecke C, Wacker I, Schödel
J, Mole DR, Campean V, Amann K, Goppelt-Struebe M, Behrens J,
Eckardt KU and Wiesener MS: The lysyl oxidases LOX and LOXL2 are
necessary and sufficient to repress E-cadherin in hypoxia: insights
into cellular transformation processes mediated by HIF-1. J Biol
Chem. 285:6658–6669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peinado H, Del Carmen Iglesias-de la Cruz
M, Olmeda D, Csiszar K, Fong KS, Vega S, Nieto MA, Cano A and
Portillo F: A molecular role for lysyl oxidase-like 2 enzyme in
snail regulation and tumor progression. EMBO J. 24:3446–3458. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lucero HA, Ravid K, Grimsby JL, Rich CB,
DiCamillo SJ, Mäki JM, Myllyharju J and Kagan HM: Lysyl oxidase
oxidizes cell membrane proteins and enhances the chemotactic
response of vascular smooth muscle cells. J Biol Chem.
283:24103–24117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kagan HM, Williams MA, Calaman SD and
Berkowitz EM: Histone H1 is a substrate for lysyl oxidase and
contains endogenous sodium borotritide-reducible residues. Biochem
Biophys Res Commun. 115:186–192. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Giampuzzi M, Oleggini R and Di Donato A:
Demonstration of in vitro interaction between tumor suppressor
lysyl oxidase and histones H1 and H2: definition of the regions
involved. Biochim Biophys Acta. 1647:245–251. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Herranz N, Dave N, Millanes-Romero A,
Morey L, Díaz VM, Lórenz-Fonfría V, Gutierrez-Gallego R, Jerónimo
C, Di Croce L, García de Herreros A and Peiró S: Lysyl oxidase-like
2 deaminates lysine 4 in histone H3. Mol Cell. 46:369–376. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jung ST, Kim MS, Seo JY, Kim HC and Kim Y:
Purification of enzymatically active human lysyl oxidase and lysyl
oxidase-like protein from Escherichia coli inclusion bodies.
Protein Expr Purif. 31:240–246. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Palamakumbura AH and Trackman PC: A
fluorometric assay for detection of lysyl oxidase enzyme activity
in biological samples. Anal Biochem. 300:245–251. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee JE and Kim Y: A tissue-specific
variant of the human lysyl oxidase-like protein 3 (LOXL3) functions
as an amine oxidase with substrate specificity. J Biol Chem.
281:37282–37290. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim MS, Kim SS, Jung ST, Park JY, Yoo HW,
Ko J, Csiszar K, Choi SY and Kim Y: Expression and purification of
enzymatically active forms of the human lysyl oxidase-like protein
4. J Biol Chem. 278:52071–52074. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pinnell SR and Martin G: The cross-linking
of collagen and elastin: enzymatic conversion of lysine in peptide
linkage to alpha-aminoadipic-delta-semialdehyde (allysine) by an
extract from bone. Proc Natl Acad Sci USA. 61:708–716. 1968.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kagan HM, Sullivan KA, Olsson TA III and
Cronlund AL: Purification and properties of four species of lysyl
oxidase from bovine aorta. Biochem J. 177:203–214. 1979.PubMed/NCBI
|
|
23
|
Sullivan KA and Kagan HM: Evidence for
structural similarities in the multiple forms of aortic and
cartilage lysyl oxidase and a catalytically quiescent aortic
protein. J Biol Chem. 257:13520–13526. 1982.PubMed/NCBI
|
|
24
|
Kuivaniemi H, Savolainen ER and Kivirikko
KI: Human placental lysyl oxidase. Purification, partial
characterization, and preparation of two specific antisera to the
enzyme. J Biol Chem. 259:6996–7002. 1984.PubMed/NCBI
|
|
25
|
Li W, Nellaiappan K, Strassmaier T, Graham
L, Thomas KM and Kagan HM: Localization and activity of lysyl
oxidase within nuclei of fibrogenic cells. Proc Natl Acad Sci USA.
94:12817–12822. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cronshaw AD, Fothergill-Gilmore LA and
Hulmes DJS: The proteolytic processing site of the precursor of
lysyl oxidase. Biochem J. 306:279–284. 1995.PubMed/NCBI
|
|
27
|
Hayashi K, Fong KS, Mercier F, Boyd CD,
Csiszar K and Hayashi M: Comparative immunocytochemical
localization of lysyl oxidase (LOX) and the lysyl oxidase-like
(LOXL) proteins: changes in the expression of LOXL during
development and growth of mouse tissues. J Mol Histol. 35:845–855.
2004. View Article : Google Scholar
|
|
28
|
Mello ML, Contente S, Vidal BC, Planding W
and Schenck U: Modulation of ras transformation affecting chromatin
supraorganization as assessed by image analysis. Exp Cell Res.
220:374–382. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kirschmann DA, Seftor EA, Nieva DR,
Mariano EA and Hendrix MJ: Differentially expressed genes
associated with the metastatic phenotype in breast cancer. Breast
Cancer Res Treat. 55:127–136. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stassar MJ, Devitt G, Brosius M, Rinnab L,
Prang J, Schradin T, Simon J, Petersen S, Kopp-Schneider A and
Zoller M: Identification of human renal cell carcinoma associated
genes by suppression subtractive hybridization. Br J Cancer.
85:1372–1382. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ren C, Yang G, Timme TL, Wheeler TM and
Thompson TC: Reduced lysyl oxidase messenger RNA levels in
experimental and human prostate cancer. Cancer Res. 58:1285–1290.
1998.PubMed/NCBI
|
|
32
|
Woznick AR, Braddock AL, Dulai M, Seymour
ML, Callahan RE, Welsh RJ, Chmielewski GW, Zelenock GB and Shanley
CJ: Lysyl oxidase expression in bronchogenic carcinoma. Am J Surg.
189:297–301. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kaneda A, Wakazono K, Tsukamoto T,
Watanabe N, Yagi Y, Tatematsu M, Kaminishi M, Sugimura T and
Ushijima T: Lysyl oxidase is a tumor suppressor gene inactivated by
methylation and loss of heterozygosity in human gastric cancers.
Cancer Res. 64:6410–6415. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kirschmann DA, Seftor EA, Fong SF, Nieva
DR, Sullivan CM, Edwards EM, Sommer P, Csiszar K and Hendrix MJ: A
molecular role for lysyl oxidase in breast cancer invasion. Cancer
Res. 62:4478–4483. 2002.PubMed/NCBI
|
|
35
|
Palamakumbura AH, Jeay S, Guo Y, Pischon
N, Sommer P, Sonenshein GE and Trackman PC: The propeptide domain
of lysyl oxidase induces phenotypic reversion of ras-transformed
cells. J Biol Chem. 279:40593–40600. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Min C, Yu Z, Kirsch KH, Zhao Y, Vora SR,
Trackman PC, Spicer DB, Rosenberg L, Palmer JR and Sonenshein GE: A
loss-of-function polymorphism in the propeptide domain of the LOX
gene and breast cancer. Cancer Res. 69:6685–6693. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao Y, Min C, Vora SR, Trackman PC,
Sonenshein GE and Kirsch KH: The lysyl oxidase pro-peptide
attenuates fibronectin-mediated activation of focal adhesion kinase
and p130Cas in breast cancer cells. J Biol Chem. 284:1385–1393.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Palamakumbura AH, Vora SR, Nugent MA,
Kirsch KH, Sonenshein GE and Trackman PC: Lysyl oxidase propeptide
inhibits prostate cancer cell growth by mechanisms that target
FGF-2-cell binding and signaling. Oncogene. 28:3390–3400. 2009.
View Article : Google Scholar : PubMed/NCBI
|
